Sign up to save your podcasts
Or
Share Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
CME credits: 0.25
Valid until: 18-11-2026
Claim your CME credit at https://reachmd.com/programs/cme/engaging-your-patient-shared-decision-making-in-hf-with-lvef40/29910/
Enhance your ability to apply shared decision-making in patients with HF and LVEF ≥40%. Through real-world clinical vignettes, Dr. Scott Solomon illustrates how to uncover patient goals, clearly communicate risks and benefits, and build collaborative treatment plans. The session emphasizes early use of SGLT2 inhibitors and finerenone to reduce hospitalizations, improve quality of life, and optimize long-term outcomes.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 18-11-2026
Claim your CME credit at https://reachmd.com/programs/cme/engaging-your-patient-shared-decision-making-in-hf-with-lvef40/29910/
Enhance your ability to apply shared decision-making in patients with HF and LVEF ≥40%. Through real-world clinical vignettes, Dr. Scott Solomon illustrates how to uncover patient goals, clearly communicate risks and benefits, and build collaborative treatment plans. The session emphasizes early use of SGLT2 inhibitors and finerenone to reduce hospitalizations, improve quality of life, and optimize long-term outcomes.
=